DaphneHaas-KoganMD

Radiation Oncology • Boston, MA

Pediatric Radiation Oncology

Professor and Chair, DFCI/BWH/BCH

Join to view full profile

Dr. Haas-Kogan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Haas-Kogan's full profile

Already have an account?

Office
75 Francis St
Boston, MA 02115
Phone+1 617-732-5500

Fax+1 617-632-2290

Education & Training

University of California (San Francisco)Residency, Radiation Oncology, 1992 - 1997
California Pacific Medical CenterInternship, Internal Medicine, 1991 - 1992
University of California San Francisco School of MedicineClass of 1991

Certifications & Licensure

CA State Medical License 1993 - 2027
MA State Medical License 2015 - 2026
ME State Medical License 2020 - 2026
NH State Medical License 2022 - 2026
RI State Medical License 2022 - 2026
CT State Medical License 2022 - 2025
FL State Medical License 2023 - 2025
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children Start of enrollment: 2012 Dec 13
Active, not recruiting
Phase 2

Publications & Presentations

PubMed

113 citations
Glucose withdrawal induces oxidative stress followed by apoptosis in glioblastoma cells but not in normal human astrocytes.
Nannette Jelluma, Xiaodong Yang, David Stokoe, Gerard I. Evan, Tobias B. Dansen
Molecular Cancer Research. 2006-05-01
52 citations
Cooperation of the HDAC inhibitor vorinostat and radiation in metastatic neuroblastoma: Efficacy and underlying mechanisms
Sabine Mueller, Xiaodong Yang, T. Sottero, Ashley Gragg, Gautam Prasad
Cancer Letters. 2011-07-28
125 citations
Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide
Gautam Prasad, T. Sottero, Xiaodong Yang, Sabine Mueller, C. David James
Neuro-Oncology. 2011-04-01

Journal Articles

Clinical Characteristics, Experiences, and Outcomes of Transgender Patients with Cancer
Danielle S Bitterman, Daphne A Haas-Kogan, JAMA Oncology
Race Disparities in Proton Radiotherapy Use for Cancer Treatment in Patients Enrolled in Children’s Oncology Group Trials
Danielle S Bitterman, Stephanie A Terezakis, Daphne A Haas-Kogan, JAMA Oncology

Authored Content

Race Disparities in Proton Radiotherapy Use for Cancer Treatment in Patients Enrolled in Children’s Oncology Group TrialsAugust 2020

Press Mentions

Vulnerability in Brain Tumors May Open Door to New TreatmentsSeptember 26th, 2022
Channeling JFK in Boston Visit, Biden Breathes New Life into Cancer ‘Moonshot’September 12th, 2022
Christ Hospital Becomes Newest Member of Dana-Farber Brigham Cancer Care CollaborativeJuly 6th, 2022
Join now to see all

Professional Memberships

Alpha Omega Alpha Honor Medical Society - AOA
Member
Radiological Society of North America - RSNA
Member
American Society of Clinical Oncology - ASCO
Member
ASTRO
Member
American Association for Cancer Research - AACR
Member
Alpha Omega Alpha Honor Medical Society - AOA
Member
American Association for Cancer Research - AACR
Member

Other Languages

Hebrew

External Links

BWH Radiation Oncologyhttp://www.brighamandwomens.org/Departments_and_Services/surgery/services/urology/Radiation-Therapy.aspx